๐ฐ Expanded Access Program News
Page 22 - Expanded Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Program. Real-time updates on events, politics, business and more.
October 25, 2021
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of...
October 20, 2021
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr. Adi Frish,...
October 20, 2021
Investegate announcements from RedHill Biopharma, RedHill to Present at BIO-Europe 2021 Conference
October 18, 2021
TEL-AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / October 18, 2021 / RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members
October 12, 2021
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment of H.
October 6, 2021
Investegate announcements from RedHill Biopharma, Talicia๏ฟฝ added to Medi-Cal CDL
October 4, 2021
Investegate announcements from RedHill Biopharma, 62% COVID19 Mortality Reduction with Oral Opaganib
October 4, 2021
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported new data from the...
October 4, 2021
62% statistically significant reduction in mortality shown for moderately severe COVID-19 patients group treated with opaganib vs. the
August 29, 2021
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results...